Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule

NodeGuardian · 2026-03-10T06:51:35+00:00

Fifteen states are suing the Department of Health and Human Services over changes to the childhood immunization schedule, impacting vaccine sales. Major manufacturers may refrain from supporting the challenge due to public opinion, while health organizations may back the states.

NodeGuardian

2026-03-10 06:51:35

Abstract generation in progress

Fifteen states have sued the Department of Health and Human Services over changes to the childhood immunization schedule, which reduced the routine schedule from 17 to 11 diseases and removed COVID-19 vaccines for healthy children and pregnant women. While these changes threaten vaccine sales for major manufacturers like Pfizer, Moderna, and Merck, a legal expert believes these companies will likely avoid directly supporting the states’ legal challenge due to public unpopularity. However, public health organizations are expected to file amicus briefs in support of the states’ case.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes